1-3 of 3
Yu Zheng
Close
Sort by
Journal Articles

Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b

Christina Chaivorapol, Pascal Beauchesne, Rowena De Jesus, William E Dowdle, Xiaoyu Chen, Alison Bayley, Yunjiang Qiu, Andrew Birnberg, Yu Zheng, Antonino Montalbano, Angela Liu, Misbah Zafar, Karl Manner, Ramya Ankala, Eleonore Tham, Heer Shah, Ben Lam, Jaclyn Lock, Lindong Weng, Kate Watts, Amanda Valdiosera, Kimberly Davis, Lei Wang, Divy Kangeyan, PhD, Nicolas Devos, Athena Wong, Jason Lih, Edward J Rebar
Journal: Blood
Blood (2022) 140 (Supplement 1): 1606–1607.
https://doi.org/10.1182/blood-2022-167627
Published: 2022
Journal Articles

Modified Intensive Induction Treatment for Elderly Acute Myeloid Leukemia Patients Based on Peripheral Blast Clearance Rate: A Phase II Single-Arm Study

Ya Li, Xiaoyang Li, Hongming Zhu, Yunxiang Zhang, Yu Chen, Qiusheng Chen, Yu Zheng, Junmin Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 1260.
https://doi.org/10.1182/blood-2021-152042
Published: 2021
Journal Articles

Long-Term Outcome of Imatinib Treatment in Chronic Myeloid Leukemia (CML) Patients in Shanghai: An International Patient Assistance Programs (GIPAP) Analysis.

Ai-hua Wang, Li Zhou, Yu Zheng, Jun-min Li, Zhi-Xiang Shen, MD, Jiong Hu, MD
Journal: Blood
Blood (2009) 114 (22): 4275.
https://doi.org/10.1182/blood.V114.22.4275.4275
Published: 2009